Weesp, Netherlands

Hendrink J Koster


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hendrink J Koster: Innovator in Medicinal Chemistry

Introduction

Hendrink J Koster is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of medicinal chemistry, particularly in the development of prodrugs for therapeutic applications. His work focuses on enhancing the efficacy of piperazine and piperidine derivatives.

Latest Patents

Hendrink J Koster holds a patent for "N-oxides as prodrugs of piperazine and piperidine derivatives." This patent relates to the N-oxides of specific piperazine and piperidine derivatives and outlines methods for their preparation. The compounds are intended for use in the manufacture of medicaments that provide beneficial effects. They are particularly relevant for treating various CNS disorders, including anxiety disorders, depression, and schizophrenia. The compounds have a general formula that is detailed in the patent specification.

Career Highlights

Koster is associated with Solvay Pharmaceuticals B.V., where he has contributed to innovative research and development in pharmaceuticals. His work has implications for the treatment of a range of mental health conditions, showcasing his commitment to improving patient outcomes through scientific advancements.

Collaborations

He has collaborated with notable colleagues such as Theodorus S M Koopman and Peter H Van Amsterdam, further enhancing the impact of his research in the pharmaceutical industry.

Conclusion

Hendrink J Koster's contributions to medicinal chemistry, particularly through his patent on piperazine and piperidine derivatives, highlight his role as an innovator in the field. His work continues to influence the development of effective treatments for various CNS disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…